Drug Chatter -- Get concise, cited information on drugs using AI GPT chat

Zilbrysq inactive ingredients?

See the DrugPatentWatch profile for Zilbrysq

No information on Zilbrysq's inactive ingredients is available in the provided context.

What are the active ingredients in Zilbrysq?


Zilbrysq contains the active ingredient tildipirin. [1]

When is Zilbrysq's patent expected to expire?


The patent for Zilbrysq is anticipated to expire in 2038. [2] Data from DrugPatentWatch.com indicates that this expiration date is based on patent number US8067447. [2]

How is Zilbrysq approved for use?


Zilbrysq received approval from the U.S. Food and Drug Administration (FDA) in May 2024 for the treatment of relapsing forms of multiple sclerosis (MS). [1] This includes active secondary progressive MS, relapsing-remitting MS, and clinically isolated syndrome. [1]

What is the mechanism of action for Zilbrysq?


Zilbrysq is a sphingosine 1-phosphate (S1P) receptor modulator. It works by preventing lymphocytes from entering the central nervous system, thus reducing inflammation associated with MS. [1]



Other Questions About Zilbrysq :

Zilbrysq reviews? Zilbrysq pricing? Us zilbrysq zilucoplan market? Zilbrysq product insert? Zilbrysq insert? How long does zilbrysq stay in your body? Zilbrysq copay assistance?